About LOEWI
LOEWI is a Healthcare company based in Munchen (Germany) founded in 2018 by Philipp Merk, Calvin Devereux, and Adrian Kapsalis, and was acquired by bioniq in January 2022. Personalized nutrient products for multiple diseases are provided. Its focus areas include Life Sciences, Nutraceuticals Tech, Dietary Supplements and Disease Specific. Its legal entity is LOEWI GmbH.
Company details
LOEWI was founded in 2018 in Munich, Germany, and operates in the health sector. Personalized nutrient products are offered for various diseases, formulated without coloring, preservatives, or technical additives, and tested to be free of heavy metals, pesticides, solvents, plasticizers, and anabolic steroids. Health analysis services are provided, including consultations with doctors. A medical history questionnaire platform is utilized to incorporate dietary habits, allergies, intolerances, pregnancy, and illnesses into recommendations.
Funding Insights of LOEWI
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of LOEWI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2020 | Seed | – | HTGF | – |
2 investors in total: 2 institutional.
Investors in LOEWI
LOEWI has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include bioniq and High-Tech Gründerfonds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are made in high-tech startups by HTGF. | htgf.de | Bonn, Germany | ||
AI-powered hyper-personalized supplements are delivered using user health data. | 2019 | bioniq.com | London, United Kingdom |
Investor details for LOEWI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of LOEWI
3 people are tracked at LOEWI (3 in leadership).
| Name | Role | Group |
|---|---|---|
Philipp Merk | Founder & Managing Director | Leadership |
Calvin Devereux | Founder & Managing Director & CTO | Leadership |
Adrian Kapsalis | Founder & Managing Director | Leadership |
Complete people profiles for LOEWI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of LOEWI
3 dated milestones of LOEWI across 4 years, from founding to its latest funding, stage changes and deals.
- Founded LOEWI is founded.
- Funding First funding round.
- Exit Acquired by bioniq.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Loewi
Complete news archive for LOEWI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LOEWI
LOEWI was founded in 2018 and raised its 1st funding round 2 years after it was founded.
LOEWI is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
LOEWI was founded in 2018 in Munich, Germany, and operates in the health sector. Personalized nutrient products are offered for various diseases, formulated without coloring, preservatives, or technical additives, and tested to be free of heavy metals, pesticides, solvents, plasticizers, and anabolic steroids. Health analysis services are provided, including consultations with doctors. A medical history questionnaire platform is utilized to incorporate dietary habits, allergies, intolerances, pregnancy, and illnesses into recommendations.
LOEWI has 2 investors. Key investors include bioniq, and High-Tech Gründerfonds.
LOEWI operates through Loewi Gmbh.
Yes. LOEWI was acquired by bioniq in January 2022.